)
Edge23 Jan 2026
Death, Taxes, and Garbage: The Story of WM
How Waste Management turned garbage into one of America's most stable business models through landfills, regulation, and nationwide scale.
Elanco Animal Health
Elanco Animal Health (ELAN) investor relations material
Elanco Animal Health 44th Annual J.P. Morgan Healthcare Conference summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.44th Annual J.P. Morgan Healthcare Conference summary13 Jan, 2026
Strategic Highlights and Industry Trends
Achieved nine consecutive quarters of growth, with mid-single-digit growth and a diversified portfolio across farm and pet segments in U.S. and international markets.
The animal health industry is projected to grow from $42B to $60B, driven by innovation, brand loyalty, pet humanization, and global protein consumption.
Five key trends include increased pet owner spending, evolving livestock health needs, omnichannel expansion, and protein market consolidation.
Focuses on a purpose-driven mission to enrich lives through food and companionship, aiming to make life better for animals and people.
Consistent, predictable growth supported by a steady pipeline of new products and innovation.
Growth, Innovation, and Financial Performance
Launched six blockbuster products since 2021, with innovation revenue guided to $840–$880 million in 2025 and a target of $1.1 billion in 2026.
Pipeline refilled to $2 billion, focusing on eight therapeutic areas and aiming for five to six new blockbusters by decade’s end.
Projects mid-single-digit organic constant currency revenue growth starting in 2025, with high single-digit EBITDA and low double-digit EPS growth, and free cash flow exceeding $1B from 2026-2028.
Adjusted EBITDA margin expansion of 200-350 bps expected by 2028.
The 'Big 6' products are expected to double revenue by 2028, with over $2B in peak sales potential from the next wave of innovation.
Product and Innovation Updates
Credelio Quattro is the fastest blockbuster to $100 million, with 30% U.S. market share and international launches planned through 2026.
Zenrelia has reached 46% of U.S. clinics and over 20% market share in early international markets, with efficacy and label improvements driving adoption.
Bafrenna (Befrena), a new monoclonal antibody for derm, launches in 1H 2024 with strong vet interest and is expected to ramp up in the second half.
Experior is nearing $200 million in sales, leads in environmental stewardship, and benefits from favorable market conditions and herd rebuilding.
The innovation pipeline includes 15 projects across eight areas, aiming for five to six blockbusters in major, growing markets by 2030.
Elanco Ascend: Detail 2026-2027 savings breakdown
Next Wave innovation: Key areas of focus
Address US vet visit volume declines impact
Sustain innovation flow beyond current blockbusters?
How will Elanco Ascend drive future EBITDA growth?
How will Befrena differentiate in the derm market?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Elanco Animal Health earnings date
Q4 202524 Feb, 2026
Elanco Animal Health
Next Elanco Animal Health earnings date
Q4 202524 Feb, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Animal Health Experts
Elanco Animal Health Inc. formerly a division of Eli Lilly, is an American company with multinational operations that specializes in animal health products and services. Elanco's portfolio includes a variety of products for both farm animals and pets, focusing on disease prevention, treatment, parasite control, and enhancing productivity in livestock. The company is headquartered in Greenfield, Indiana, and its shares are listed on the NYSE.
Foundation and Divestiture
Elanco was initially founded as a division of Eli Lilly in 1954. Initially, the division focused on feed additives to promote growth in livestock, later expanding to include a broader range of animal health products, such as vaccines and treatments for both livestock and pets. In 2019, Elanco was divested from Eli Lilly, becoming a standalone company. Today, Elanco is one of the largest animal health companies in the world, operating in the same sector as companies such as Zoetis and Virbac.
For Pets
Elanco produces products aimed at both companion animals and livestock. Its revenue is split nearly 50/50 between products for livestock and pets. Its product range for companion animals encompasses therapeutics, vaccines, parasiticides, and dermatology products. These offerings aim to address various health issues, such as flea and tick infestations, arthritis, and chronic pain, as well as supporting overall wellness. This is done both through medications, as well as through things such as anti-flea collars and similar products.
For Livestock
Elanco also plays a significant role in the livestock sector. The company offers a range of products and services aimed at improving the health, productivity, and well-being of farm animals such as cattle, poultry, and swine. Their portfolio for livestock includes vaccines, feed additives, antimicrobials, and products for parasite control and pain management. These products are designed to address health challenges and diseases common in livestock, enhance growth and efficiency, and ensure food safety.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage